 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| RovathinS34256 | 2,3,4,5-tetrahydro-7-methoxy-1,4-Benzothiazepine | 145903-31-7 | 95% |
| RovathinS34257 | 2-bromo-3-(bromomethyl)Pyridine | 94446-97-6 | 95% |
| RovathinS34258 | 4-chloro-6,7-dihydro-5H-Cyclopenta[b]pyridine | 54664-55-0 | 95% |
| RovathinS34259 | 6-bromo-4-methylQuinoline | 41037-28-9 | 95% |
| RovathinS34260 | 2-Benzofuranacetic acid methyl ester | 39581-61-8 | 95% |
| RovathinS34261 | 3-hydroxy-2-Pyrrolidinone | 15166-68-4 | 95% |
| RovathinS34262 | 4-amino-3-mercaptoBenzoic acid hydrochloride | 14543-45-4 | 95% |
| RovathinS34263 | Bicyclo[2.2.2]octane-1,4-dicarboxylic acid 1,4-dimethyl ester | 1459-96-7 | 95% |
| RovathinS34264 | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-Triazolo[3,4-f][1,6]naphthyridin-3(2H)-one dihydrochloride | 1032350-13-2 | 95% |
| RovathinS34265 | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-Triazolo[3,4-f][1,6]naphthyridin-3(2H)-one | 1032349-93-1 | 95% |
| RovathinS34266 | N-cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]Urea | 896466-04-9 | 95% |
| RovathinS34267 | AT 7519 | 1109289-42-0 | 95% |
| RovathinS34268 | 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]Bicyclo[2.2.2]octane-1-acetic acid acetate | 942999-67-9 | 95% |
| RovathinS34269 | (2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]Pentanamide | 603139-12-4 | 95% |
| RovathinS34270 | 42-(dimethylphosphinate)Rapamycin | 572924-54-0 | 95% |
| RovathinS34271 | 5-chloro-1-[(3,4-dichlorophenyl)methyl]-1H-Indole-2,3-dione 3-[O-(3-chloro-1-oxopropyl)oxime] | 320420-75-5 | 95% |
| RovathinS34272 | 5-chloro-1-[(3,4-dichlorophenyl)methyl]-1H-Indole-2,3-dione 3-[O-(1-oxopentyl)oxime] | 320420-74-4 | 95% |
| RovathinS34273 | 5-chloro-1-[(3,4-dichlorophenyl)methyl]-1H-Indole-2,3-dione 3-[O-(3-methyl-1-oxobutyl)oxime] | 303998-57-4 | 95% |
| RovathinS34274 | 5-chloro-1-[(3,4-dichlorophenyl)methyl]-1H-Indole-2,3-dione 3-[O-(2-chloroacetyl)oxime] | 303998-56-3 | 95% |
| RovathinS34275 | AZD3582 | 170591-17-0 | 95% |
| RovathinS34276 | 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]Rapamycin | 162635-04-3 | 95% |
| RovathinS34277 | (3R)-3-[[[8-fluoro-4-(3-methoxypropoxy)-6-methyl-2-quinolinyl]carbonyl](1-methylethyl)amino]-1-Piperidinecarboxylic acid 1,1-dimethylethyl ester | 1078129-57-3 | 95% |
| RovathinS34278 | 8-fluoro-4-(3-methoxypropoxy)-6-methyl-N-(1-methylethyl)-N-(3R)-3-piperidinyl-2-Quinolinecarboxamide dihydrochloride | 1078128-56-9 | 95% |
| RovathinS34279 | 8-fluoro-4-(3-methoxypropoxy)-6-methyl-N-(1-methylethyl)-N-(3R)-3-piperidinyl-2-Quinolinecarboxamide | 1078203-42-5 | 95% |
| RovathinS34280 | 3-butyl-10H-Indeno[2,1-e]-1,2,4-triazolo[4,3-b][1,2,4]triazin-10-one O-2-propen-1-yloxime | 1022084-04-3 | 95% |
| RovathinS34281 | 3-(3,4-difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethyl-Azepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester | 629664-81-9 | 95% |
| RovathinS34282 | 5-chloro-1-[(3,4-dichlorophenyl)methyl]-1H-Indole-2,3-dione 3-(O-acetyloxime) | 303998-55-2 | 95% |
| RovathinS34283 | 2-(aminoiminomethyl)benzo[b]thiophen-6-yl ester 2-Thiophenecarboxylic acid methanesulfonate | 217099-44-0 | 95% |
| RovathinS34284 | Libenzapril | 109214-55-3 | 95% |
| RovathinS34285 | 5-bromo-4-Pyrimidinecarboxylic acid methyl ester | 1009826-93-0 | 95% |
|
|
|
|
